Remdesivir Clinical Trials
6 recruitingDrug
Phase 23Phase 31Phase 41
Showing 1–6 of 6 trials
Recruiting
Phase 2
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Hematopoietic and Lymphatic System NeoplasmAutoimmune DiseaseRespiratory Syncytial Virus Infection
Fred Hutchinson Cancer Center60 enrolled3 locationsNCT06817889
Recruiting
Phase 2
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
COVID-19
University of Oxford3,800 enrolled7 locationsNCT05041907
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Lactating Women on Select DOIBreastfed Infants of Mothers on Select DOI
Duke University1,600 enrolled22 locationsNCT03511118
Recruiting
Phase 2
Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV
Respiratory Syncytial Virus (RSV)
PENTA Foundation120 enrolled8 locationsNCT06873633
Recruiting
Phase 4
Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial
SARS CoV-2 Post-Acute Sequelae
Mount Sinai Hospital, Canada118 enrolled4 locationsNCT06792214
Recruiting
Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707